Recro Pharma, Inc. - stock earnings
Stock symbol REPH is outdated, potentially delisted? Maybe it is available on other exchange?
REPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q3 | -3.5 million USD | 18.2 million USD |
| 2021Q2 | 1.2 million USD | 18.0 million USD |
| 2021Q1 | -6.8 million USD | 16.8 million USD |
| 2020Q4 | -11.7 million USD | 9.9 million USD |
| 2020Q3 | -2.1 million USD | 19.3 million USD |
REPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -27.5 million USD | 66.5 million USD |
| 2019 | -18.6 million USD | 99.2 million USD |
| 2018 | -79.7 million USD | 77.3 million USD |
| 2017 | -50.1 million USD | 71.8 million USD |
REPH
Price: $2.09
52 week price:
Earnings Per Share: -0.29 USD
P/E Ratio: -0.81
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 177438
Ebitda: -8.8 millionMarket Capitalization: 79.2 million